ArticleJournal of the Chinese Medical Association : JCMA2022

Abandon ifosfamide-based regimen and use paclitaxel-carboplatin regimen for the treatment of uterine carcinosarcoma.

Szu-Ting Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.